Cancer News and Research

Latest Cancer News and Research

Researchers discover genetic risk factor for premature birth

Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth.

7 May 2014

Protein molecule seems to slow progression of deadly lung disease

Researchers at the University of Illinois at Chicago College of Medicine have discovered a protein molecule that seems to slow the progression of pulmonary fibrosis, a progressive lung disease that is often fatal three to five years after diagnosis.

7 May 2014

Snacking linked with abdominal fat and fatty liver

Researchers from The Netherlands found that snacking on high-fat and high-sugar foods was independently associated with abdominal fat and fatty liver (hepatic steatosis).

7 May 2014

Novel bioinformatics approach suggests antimicrobial drug may help in treating advanced kidney cancer

Developing and testing a new anti-cancer drug can cost billions of dollars and take many years of research.

6 May 2014

Loxo Oncology announces closing of $24 million Series B private financing round

Loxo Oncology, Inc., a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced today that it has closed a $24 million Series B private financing round led by New Enterprise Associates.

6 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

FDA accepts Merck's MK-3475 BLA for review

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.

6 May 2014

Family House to host first-ever crowdfunding campaign to build free, temporary accommodation

Family House will hold its first-ever crowdfunding campaign to raise $100,000 for the new Nancy and Stephen Grand Family House in Mission Bay.

6 May 2014

Concise analysis of global disposable gloves market

MRRBIZ includes new market research report "Disposable Gloves Market For Medical and Non-Medical (Food, Cleanroom, Industrial And Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its large collection of research report.

6 May 2014

New study explores how bacterial pathogen Yersinia tries to outsmart immune cell responses

A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and kill human cells.

6 May 2014

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.

6 May 2014

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

6 May 2014

The Jeffrey Epstein VI Foundation supports Sunscreen Innovation Act to combat melanoma

Sunscreens are long overdue for a makeover: in fact active ingredients in US sunscreens haven't been updated for fifteen years, despite dermatologist and oncologist warnings that US sunscreens are not effective enough.

6 May 2014

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens - the number who have fallen into the "coverage gap" is estimated at 5 million - amazes and frustrates health experts.

6 May 2014

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.

6 May 2014

Kinex receives FDA allowance for Oratecan anti-cancer drug irinotecan with enhanced oral absorption

Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.

6 May 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease.

6 May 2014

Massachusetts' health reform law decreases mortality by 2.9%

In the first four years after Massachusetts instituted comprehensive health reform in 2006, mortality in the state decreased by 2.9% compared with similar populations in states that didn't expand health coverage, according to a new study led by Harvard School of Public Health researchers.

6 May 2014

Covagen begins COVA322 Phase Ib/IIa study to treat patients with rheumatoid and psoriatic arthritis

Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor.

6 May 2014

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.

6 May 2014

Cancer News and Research

Latest Cancer News and Research

Researchers discover genetic risk factor for premature birth

Protein molecule seems to slow progression of deadly lung disease

Snacking linked with abdominal fat and fatty liver

Novel bioinformatics approach suggests antimicrobial drug may help in treating advanced kidney cancer

Loxo Oncology announces closing of $24 million Series B private financing round

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

FDA accepts Merck's MK-3475 BLA for review

Family House to host first-ever crowdfunding campaign to build free, temporary accommodation

Concise analysis of global disposable gloves market

New study explores how bacterial pathogen Yersinia tries to outsmart immune cell responses

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

The Jeffrey Epstein VI Foundation supports Sunscreen Innovation Act to combat melanoma

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Kinex receives FDA allowance for Oratecan anti-cancer drug irinotecan with enhanced oral absorption

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Massachusetts' health reform law decreases mortality by 2.9%

Covagen begins COVA322 Phase Ib/IIa study to treat patients with rheumatoid and psoriatic arthritis

Teva's SYNRIBO for injection receives FDA approval for home administration

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in